Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

By Michael Miller. New England Journal of Medicine, 2004

2,214 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. (2006, background): “tion of patients receiving statins are not meeting established targets that are recommended in guidelines for cholesterol reduction,(14,15) and newer data suggest even more aggressive targets.(16,17) Only a minority of patients were at target goals for blood pressure, glucose, cholesterol, body weig”
Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (2014, background): “In 2 trials (46,47), patients were previously treated with a moderately intensive statin and in 2 trials 75% to 97% of patients had not received prior statin therapy (48,79).”
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Specific statins and doses are noted in bold that were evaluated in RCTs (17,18,46-48,64-67,69-78) included in CQ1, CQ2 and the CTT 2010 meta-analysis included in CQ3 (20).”